Antonio Javier
Carcas Sansuan
Publicaciones en las que colabora con Antonio Javier Carcas Sansuan (7)
2019
-
Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains
Journal of Global Antimicrobial Resistance, Vol. 19, pp. 241-251
2005
-
Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers
Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 742-747
-
Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs Differ
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 3, pp. 996-1001
-
Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: A phase I, open-label, noncomparative clinical trial in healthy volunteers
Clinical Therapeutics, Vol. 27, Núm. 7, pp. 1043-1049
2004
-
Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation
Journal of Antimicrobial Chemotherapy, Vol. 54, Núm. 6, pp. 1148-1151
2003
-
Does Acetaminophen Interfere in the Antibiotic Treatment of Acute Otitis Media Caused by a Penicillin-Resistant Pneumococcus Strain? A Gerbil Model
Pediatric Research, Vol. 54, Núm. 6, pp. 913-918
2001
-
Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: Phase I study
Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 6, pp. 1876-1878